Forrest, E., , Richardson, P., Masson, S., Ryder, S., Thursz, M., … Management, G. S. T. (2018). ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be Established. The American Journal of Gastroenterology. https://doi.org/10.1038/s41395-018-0076-x (Original work published 2018)

Forrest, E., , Richardson, P., Masson, S., Ryder, S., Thursz, M., … Management, G. S. T. (2018). Reply to: "The long-term prognosis of alcoholic hepatitis is poor and independent of disease severity for patients surviving an acute episode". Journal of Hepatology, 68(6), 1332. https://doi.org/10.1016/j.jhep.2018.02.023

Forrest, E., , Richardson, P., Masson, S., Ryder, S., Thursz, M., … Management, G. S. T. (2018). Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis. Journal of Hepatology, 68(3), 511-518. https://doi.org/10.1016/j.jhep.2017.11.017

Vergis, N., , Knapp, S., Maurice, J., Allison, M., Austin, A., … Thursz, M. (2017). In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA. Gastroenterology, 152(5), 1068-1077.e4. https://doi.org/10.1053/j.gastro.2016.12.019

Forlano, R., Harlow, C., Mullish, B., Thursz, M., Manousou, P., & Yee, M. (2021). Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease. The International Journal of Eating Disorders, 54(11), 2025-2030. https://doi.org/10.1002/eat.23584